Anti-superoxide and anti-peroxynitrite strategies in pain suppression

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 5, 2012, Pages 815-821

  Janes, Kali ^a   Neumann, William L ^b   Salvemini, Daniela ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

Central sensitization; Nociception; Pain; Peroxynitrite; Superoxide

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIPAIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GLUTAMIC ACID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; IRON TETRAKIS 2 (N TRIETHYLENE GLYCOL MONOMETHYL ETHER)PYRIDYL PORPHYRIN; N TERT BUTYL ALPHA PHENYLNITRONE; PEROXYNITRITE; PORPHYRIN DERIVATIVE; PORPHYRIN MANGANESE; PROTEIN KINASE; SRI 110; SRI 6; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; SYNAPTOPHYSIN; TEMPOL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CATALYST; DRUG EFFICACY; DRUG TOLERANCE; FACE PAIN; HUMAN; HYPERALGESIA; HYPERSENSITIVITY; INFLAMMATION; MICROGLIA; MITOCHONDRIAL ENERGY TRANSFER; NEUROPATHIC PAIN; NEUROTRANSMISSION; NITRATION; NOCICEPTION; OROFACIAL PAIN; PAIN; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

HUMANS; PAIN MANAGEMENT; PEROXYNITROUS ACID; SUPEROXIDES;

EID: 84858159420     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.12.008     Document Type: Article

References (106)

1. Melnikova I. Pain market. Nat. Rev. Drug Discov. 2010, 9:589-590.
2. Foley K.M. Misconceptions and controversies regarding the use of opioids in cancer pain. Anticancer Drugs 1995, 6(Suppl 3):4-13.
3. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby V.J., Porreca F. Antinociceptive and nociceptive actions of opioids. J. Neurobiol. 2004, 61:126-148.
4. Grosser T., Fries S., FitzGerald G.A. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J. Clin. Invest. 2006, 116:4-15.
5. Salvemini D., Doyle T.M., Cuzzocrea S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem. Soc. Trans. 2006, 34:965-970.
6. Salvemini D., Riley D.P., Cuzzocrea S. SOD mimetics are coming of age. Nat. Rev. Drug Discov. 2002, 1:367-374.
7. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2659-2663.
8. Salvemini D., Jensen M.P., Riley D.P., Misko T.P. Therapeutic manipulations of peroxynitrite. Drug News Perspect. 1998, 11:204-214.
9. Batinic-Haberle I., Reboucas J.S., Spasojevich I. Superoxide dismutase mimics: chemistry, pharmacology and therapeutic potential. Antioxid. Redox Signal. 2010, 13(6):877-918.
10. Obrosova I.G., Drel V.R., Oltman C.L., Mashtalir N., Tibrewala J., Groves J.T., Yorek M.A. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1645-E1655.
11. Drel V.R., Pacher P., Vareniuk I., Pavlov I., Ilnytska O., Lyzogubov V.V., Tibrewala J., Groves J.T., Obrosova I.G. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur. J. Pharmacol. 2007, 569:48-58.
12. Rausaria S.K., Andrew Salvemini, Daniela Neumann, William L. Metal-charge-shielded manganese porphyrins are potent orally active peroxynitrite decomposition catalysts, abstracts of papers. 241st ACS National Meeting & Exposition, Anaheim, CA, United States, March 27-31, 2011 2011, (MEDI-53).
13. Batinic-Haberle I., Reboucas J.S., Spasojevic I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid. Redox Signal. 2010, 13:877-918.
14. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulos H., Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 1992, 5:834-842.
15. Rausaria S., Ghaffari M.M.E., Kamadulski A., Rodgers K., Bryant L., Chen Z., Doyle T., Shaw M.J., Salvemini D., Neumann W.L. Retooling manganese(III) porphyrin-based peroxynitrite decomposition catalysts for selectivity and oral activity: a potential new strategy for treating chronic pain. J. Med. Chem. 2011, 54(24):8658-8669.
16. Rausaria S., Kamadulski A., Rath N.P., Bryant L., Chen Z., Salvemini D., Neumann W.L. Manganese(III) complexes of bis(hydroxyphenyl)dipyrromethenes are potent orally active peroxynitrite scavengers. J. Am. Chem. Soc. 2011, 133:4200-4203.
17. Radi R.A., Rubbo H., Prodanov E. Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactions. Biochim. Biophys. Acta 1989, 994:89-93.
18. Salvemini D., Neumann W. Targeting peroxynitrite driven nitroxidative stress with synzymes: a novel therapeutic approach in chronic pain management. Life Sci. 2010, 86:604-614.
19. Wang Z.Q., Porreca F., Cuzzocrea S., Galen K., Lightfoot R., Masini E., Muscoli C., Mollace V., Ndengele M., Ischiropoulos H., Salvemini D. A newly identified role for superoxide in inflammatory pain. J. Pharmacol. Exp. Ther. 2004, 309:869-878.
20. Ndengele M.M., Cuzzocrea S., Esposito E., Mazzon E., Di Paola R., Matuschak G.M., Salvemini D. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J. 2008, 22:3154-3164.
21. Yeo J.F., Ling S.F., Tang N., Ong W.Y. Antinociceptive effect of CNS peroxynitrite scavenger in a mouse model of orofacial pain. Exp. Brain Res. 2008, 184:435-438.
22. Muscoli C., Cuzzocrea S., Ndengele M.M., Mollace V., Porreca F., Fabrizi F., Esposito E., Masini E., Matuschak G.M., Salvemini D. Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J. Clin. Invest. 2007, 117:3530-3539.
23. Khattab M.M. TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion. Eur. J. Pharmacol. 2006, 548:167-173.
24. Gao X., Kim H.K., Chung J.M., Chung K. Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 2007, 131:262-271.
25. Park E.S., Gao X., Chung J.M., Chung K. Levels of mitochondrial reactive oxygen species increase in rat neuropathic spinal dorsal horn neurons. Neurosci. Lett. 2006, 391:108-111.
26. Siniscalco D., Fuccio C., Giordano C., Ferraraccio F., Palazzo E., Luongo L., Rossi F., Roth K.A., Maione S., de Novellis V. Role of reactive oxygen species and spinal cord apoptotic genes in the development of neuropathic pain. Pharmacol. Res. 2007, 55:158-166.
27. Tal M. A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy. NeuroReport 1996, 7:1382-1384.
28. Kim H.K., Zhang Y.P., Gwak Y.S., Abdi S. Phenyl N-tert-butylnitrone, a free radical scavenger, reduces mechanical allodynia in chemotherapy-induced neuropathic pain in rats. Anesthesiology 2010, 112:432-439. (410.1097/ALN.1090b1013e3181ca1031bd).
29. Fidanboylu M., Griffiths L.A., Flatters S.J.L. Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy. PLoS One 2011, 6:e25212.
30. Muscoli C., Cuzzocrea S., Riley D.P., Zweier J.L., Thiemermann C., Wang Z.Q., Salvemini D. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol. 2003, 140:445-460.
31. Little J.W., Doyle T., Salvemini D. Reactive nitroxidative species and nociceptive processing: determining the roles for nitric oxide, superoxide, and peroxynitrite in pain. Amino Acids 2010, [Electronic publication ahead of print].
32. Salvemini D., Little J.W., Doyle T., Neumann W.L. Roles of reactive oxygen and nitrogen species in pain. Free Radic. Biol. Med. 2011, 51:951-966.
33. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 1969, 244:6049-6055.
34. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free. Radic. Res. 1993, 18:195-199.
35. Liaudet L., Vassalli G., Pacher P. Role of peroxynitrite in the redox regulation of cell signal transduction pathways. Front. Biosci. 2009, 14:4809-4814.
36. Macmillan-Crow L.A., Cruthirds D.L. Invited review: manganese superoxide dismutase in disease. Free. Radic. Res. 2001, 34:325-336.
37. Muscoli C., Mollace V., Wheatley J., Masini E., Ndengele M., Wang Z.Q., Salvemini D. Superoxide-mediated nitration of spinal manganese superoxide dismutase: a novel pathway in N-methyl-d-aspartate-mediated hyperalgesia. Pain 2004, 111:96-103.
38. St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002, 277:44784-44790.
39. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 1996, 328:85-92.
40. Sculptoreanu A., Aura Kullmann F., de Groat W.C. Neurokinin 2 receptor-mediated activation of protein kinase C modulates capsaicin responses in DRG neurons from adult rats. Eur. J. Neurosci. 2008, 27:3171-3181.
41. Kohno T., Wang H., Amaya F., Brenner G.J., Cheng J.K., Ji R.R., Woolf C.J. Bradykinin enhances AMPA and NMDA receptor activity in spinal cord dorsal horn neurons by activating multiple kinases to produce pain hypersensitivity. J. Neurosci. 2008, 28:4533-4540.
42. Velazquez K.T., Mohammad H., Sweitzer S.M. Protein kinase C in pain: involvement of multiple isoforms. Pharmacol. Res. 2007, 55:578-589.
43. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J. Pain 2009, 10:895-926.
44. Hongpaisan J., Winters C.A., Andrews S.B. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J. Neurosci. 2004, 24:10878-10887.
45. Balafanova Z., Bolli R., Zhang J., Zheng Y., Pass J.M., Bhatnagar A., Tang X.L., Wang O., Cardwell E., Ping P. Nitric oxide (NO) induces nitration of protein kinase Cepsilon (PKCepsilon), facilitating PKCepsilon translocation via enhanced PKCepsilon-RACK2 interactions: a novel mechanism of no-triggered activation of PKCepsilon. J. Biol. Chem. 2002, 277:15021-15027.
46. Chakraborti T., Das S., Chakraborti S. Proteolytic activation of protein kinase Calpha by peroxynitrite in stimulating cytosolic phospholipase A2 in pulmonary endothelium: involvement of a pertussis toxin sensitive protein. Biochemistry 2005, 44:5246-5257.
47. Cuzzocrea S., Salvemini D. Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes. Kidney Int. 2007, 71:290-297.
48. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7240-7244.
49. Markey C.M., Alward A., Weller P.E., Marnett L.J. Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities. J. Biol. Chem. 1987, 262:6266-6279.
50. Trostchansky A., O'Donnell V.B., Goodwin D.C., Landino L.M., Marnett L.J., Radi R., Rubbo H. Interactions between nitric oxide and peroxynitrite during prostaglandin endoperoxide H synthase-1 catalysis: a free radical mechanism of inactivation. Free Radic. Biol. Med. 2007, 42:1029-1038.
51. Mollace V., Muscoli C., Masini E., Cuzzocrea S., Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol. Rev. 2005, 57:217-252.
52. Xu X., Wang P., Zou X., Li D., Fang L., Gong K., Lin Q. The effects of sympathetic outflow on upregulation of vanilloid receptors TRPV(1) in primary afferent neurons evoked by intradermal capsaicin. Exp. Neurol. 2010, 222:93-107.
53. Amadesi S., Cottrell G.S., Divino L., Chapman K., Grady E.F., Bautista F., Karanjia R., Barajas-Lopez C., Vanner S., Vergnolle N., Bunnett N.W. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice. J. Physiol. 2006, 575:555-571.
54. Mayer D.J., Mao J., Holt J., Price D.D. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7731-7736.
55. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., Inturrisi C.E. The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-l-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 1994, 56:69-75.
56. Zanelli S.A., Ashraf Q.M., Mishra O.P. Nitration is a mechanism of regulation of the NMDA receptor function during hypoxia. Neuroscience 2002, 112:869-877.
57. Brenner G.J., Ji R.R., Shaffer S., Woolf C.J. Peripheral noxious stimulation induces phosphorylation of the NMDA receptor NR1 subunit at the PKC-dependent site, serine-896, in spinal cord dorsal horn neurons. Eur. J. Neurosci. 2004, 20:375-384.
58. Le Guen S., Catheline G., Besson J.M. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat. Eur. J. Pharmacol. 1999, 373:1-11.
59. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
60. Brustovetsky T., Purl K., Young A., Shimizu K., Dubinsky J.M. Dearth of glutamate transporters contributes to striatal excitotoxicity. Exp. Neurol. 2004, 189:222-230.
61. Liaw W.J., Stephens R.L., Binns B.C., Chu Y., Sepkuty J.P., Johns R.A., Rothstein J.D., Tao Y.X. Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain 2005, 115:60-70.
62. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
63. Mao J., Sung B., Ji R.R., Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci. 2002, 22:8312-8323.
64. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 2002, 64:1037-1048.
65. Gorg B., Qvartskhava N., Voss P., Grune T., Haussinger D., Schliess F. Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration. FEBS Lett. 2007, 581:84-90.
66. Chen Z., Muscoli C., Doyle T., Bryant L., Cuzzocrea S., Mollace V., Mastroianni R., Masini E., Salvemini D. NMDA-receptor activation and nitroxidative regulation of the glutamatergic pathway during nociceptive processing. Pain 2010, 149:100-106.
67. Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med. 2005, 257:139-155.
68. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. 2009, 10:23-36.
69. Cao H., Zhang Y.Q. Spinal glial activation contributes to pathological pain states. Neurosci. Biobehav. Rev. 2008, 32:972-983.
70. Bradesi S. Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol. Motil. 2010, 22:499-511.
71. Bradesi S., Eutamene H., Theodorou V., Fioramonti J., Bueno L. Effect of ovarian hormones on intestinal mast cell reactivity to substance P. Life Sci. 2001, 68:1047-1056.
72. Palsson-McDermott E.M., O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113:153-162.
73. Watkins L.R., Hutchinson M.R., Rice K.C., Maier S.F. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 2009, 30:581-591.
74. Svensson C.I., Marsala M., Westerlund A., Calcutt N.A., Campana W.M., Freshwater J.D., Catalano R., Feng Y., Protter A.A., Scott B., Yaksh T.L. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J. Neurochem. 2003, 86:1534-1544.
75. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., Maier S.F. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain, behavior, and immunity 2007, 21:131-146.
76. Masini E., Bani D., Vannacci A., Pierpaoli S., Mannaioni P.F., Comhair S.A., Xu W., Muscoli C., Erzurum S.C., Salvemini D. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. Free Radic. Biol. Med. 2005, 39:520-531.
77. Pacher P., Szabo C. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. Am. J. Pathol. 2008, 173:2-13.
78. Veres B., Radnai B., Gallyas F., Varbiro G., Berente Z., Osz E., Sumegi B. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J. Pharmacol. Exp. Ther. 2004, 310:247-255.
79. Ha H.C., Hester L.D., Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. 2002, 99:3270-3275.
80. Pingle S.C., Matta J.A., Ahern G.P. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb. Exp. Pharmacol. 2007, 155-171.
81. Davis J.B., Gray J., Gunthorpe M.J., Hatcher J.P., Davey P.T., Overend P., Harries M.H., Latcham J., Clapham C., Atkinson K., Hughes S.A., Rance K., Grau E., Harper A.J., Pugh P.L., Rogers D.C., Bingham S., Randall A., Sheardown S.A. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000, 405:183-187.
82. Palazzo E., de Novellis V., Marabese I., Cuomo D., Rossi F., Berrino L., Maione S. Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur. J. Pharmacol. 2002, 439:69-75.
83. Li H.B., Mao R.R., Zhang J.C., Yang Y., Cao J., Xu L. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol. Psychiatry 2008, 64:286-292.
84. Varga A., Bolcskei K., Szoke E., Almasi R., Czeh G., Szolcsanyi J., Petho G. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience 2006, 140:645-657.
85. 2+/calmodulin-dependent kinase II regulates its vanilloid binding. J. Biol. Chem. 2004, 279:7048-7054.
86. Chuang H.H., Lin S. Oxidative challenges sensitize the capsaicin receptor by covalent cysteine modification. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:20097-20102.
87. Leonelli M., Martins D.O., Britto L.R. TRPV1 receptors are involved in protein nitration and Muller cell reaction in the acutely axotomized rat retina. Exp. Eye Res. 2010, 91:755-768.
88. Yoshimura M., Nishi S. Primary afferent-evoked glycine- and GABA-mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro. J. Physiol. 1995, 482:29-38.
89. Yowtak J., Lee K.Y., Kim H.Y., Wang J., Kim H.K., Chung K., Chung J.M. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 2011, 152:844-852.
90. Porreca F., Ossipov M.H., Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002, 25:319-325.
91. Doyle T., Bryant L., Batinic-Haberle I., Little J., Cuzzocrea S., Masini E., Spasojevic I., Salvemini D. Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Neuroscience 2009, 164(2):702-710.
92. Lee I., Kim H.K., Kim J.H., Chung K., Chung J.M. The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 2007, 133:9-17.
93. Kim H.K., Park S.K., Zhou J.L., Taglialatela G., Chung K., Coggeshall R.E., Chung J.M. Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 2004, 111:116-124.
94. De Felice M., Sanoja R., Wang R., Vera-Portocarrero L., Oyarzo J., King T., Ossipov M.H., Vanderah T.W., Lai J., Dussor G.O., Fields H.L., Price T.J., Porreca F. Engagement of descending inhibition from the rostral ventromedial medulla protects against chronic neuropathic pain. Pain 2011, 152(12):2701-2709.
95. Urban M.O., Coutinho S.V., Gebhart G.F. Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil. Pain 1999, 81:45-55.
96. Carlson J.D., Maire J.J., Martenson M.E., Heinricher M.M. Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury. J. Neurosci. 2007, 27:13222-13231.
97. Miki K., Zhou Q.Q., Guo W., Guan Y., Terayama R., Dubner R., Ren K. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J. Neurophysiol. 2002, 87:750-760.
98. Terayama R., Dubner R., Ren K. The roles of NMDA receptor activation and nucleus reticularis gigantocellularis in the time-dependent changes in descending inhibition after inflammation. Pain 2002, 97:171-181.
99. Roberts J., Ossipov M.H., Porreca F. Glial activation in the rostroventromedial medulla promotes descending facilitation to mediate inflammatory hypersensitivity. Eur. J. Neurosci. 2009, 30:229-241.
100. Little J.W.C., Doyle T., Salvemini D. Supraspinal descending facilitation of central sensitization depends on peroxynitrite regulation of opioid signaling. J. Pain 2011, 12(S2):36.
101. Little J.W.C., Doyle T., Salvemini D. Superoxide derived peroxynitrite is essential to supraspinal descending facilitation of nociception. FASEB J. 2011, 25:674.2.
102. Li Z., Ji G., Neugebauer V. Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J. Neurosci. 2011, 31:1114-1127.
103. Ji G., Neugebauer V. Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons. J. Neurophysiol. 2010, 104:218-229.
104. Bennett G.J. Pathophysiology and animal models of cancer-related painful peripheral neuropathy. Oncologist 2010, 15:9-12.
105. Janes K., Bryant L., Salvemini D. Scavenging peroxynitrite blocks the development of paclitaxel, oxaliplatin and bortezomib-induced neuropathic pain, Abstract, Neuroscience 2011, Washington DC, United States, November 12-16 2011.
106. Doyle T.C., Salvemini D. Peroxynitrite decomposition catalysts block paclitaxel-induced neuropathic pain: microarray analysis of spinal cord gene expression. J. Pain 2011, 12(S2):37.